Honbridge Holdings Limited — Proxy Solicitation & Information Statement 2025

May 28, 2025

M

HONBRIDGE HOLDINGS LIMITED

洪橋集團有限公司

(Incorporated in the Cayman Islands with limited liability)

(Stock Code: 8137)

PROXY FORM FOR USE AT THE ANNUAL GENERAL MEETING

TO BE HELD ON MONDAY, 23 JUNE 2025 (OR ANY ADJOURNMENT THEREOF)

I/We (Note 1)

of

being the registered holder(s) of (Note 2)

shares of HK$0.001 each in the share capital of Honbridge Holdings Limited (the “Company”), HEREBY APPOINT the chairman of the Meeting

or (Note 3)

of

as my/our proxy to attend and vote for me/us and on my/our behalf at the annual general meeting of the Company (the “Meeting”) to be held at Unit 5402, 54th Floor, Central Plaza, 18 Harbour Road, Wanchai, Hong Kong on Monday, 23 June 2025 at 10:00 a.m. (or any adjournment thereof) on the undermentioned resolutions as indicated, and, if no such indication is given, as my/our proxy thinks fit:

ORDINARY RESOLUTIONS		For (Note 4)	Against (Note 4)
1.	To review and adopt the audited financial statements together with the reports of the directors of the Company (the “Directors”) and auditors of the Company for the year ended 31 December 2024.
2(a)	(i) To re-elect Mr. Xu Zhihao as an executive Director;
	(ii) To re-elect Mr. Xu Bing as an executive Director;
	(iii) To re-elect Mr. Chen Shengjie as an executive Director;
	(iv) To re-elect Ms. Gu Wenting as an executive Director;
	(v) To elect Mr. Huang Yongzhong as an independent non-executive Director;
	(vi) To elect Mr. Wang Baogang as an independent non-executive Director; and
	(vii) To elect Dr. Wang Jiwei as an independent non-executive Director;
2(b)	To authorise the board of Directors to fix the Directors’ remuneration.
3.	To re-appoint BDO Limited as the auditors of the Company and to authorise the board of Directors to fix their remuneration.
4(A)	To grant an issue mandate authorising the Directors to allot and issue new shares not exceeding 20% of the total number of issued shares of the Company (“Shares”).
4(B)	To grant a general mandate to the Directors to repurchase shares not exceeding 10% of the total number of issued Shares.
4(C)	To extend the issue mandate granted to the Directors to issue shares by the number of Shares repurchased.

• The full text of the above resolutions is set out in the notice of the Meeting dated 29 May 2025.

Date this __ day of __, 2025

Signed (Note 5): _______

Notes:

1. Full name(s) and address(es) to be inserted in the BLOCK CAPITALS. The name of all joint holders should be stated.

2. Please insert the number of Shares registered in your name(s). If no number is inserted, this proxy form will be deemed to relate to all the Shares in the Company registered in your name(s).

3. If any proxy other than the Chairman of the Meeting is preferred, strike out “the Chairman of the Meeting or” and insert the name and address of the proxy desired in the space provided. Any alteration made to this proxy form must be initialled by the person who signs it.

4. IMPORTANT: If you wish to vote for any resolutions, tick the appropriate boxes marked “FOR”. If you wish to vote against any resolutions, tick the appropriate boxes marked “AGAINST”. Failure to complete the boxes will entitle your proxy to cast his votes at his discretion.

5. This proxy form must be signed by you or your attorney duly authorised in writing or, in the case of a corporation, must be executed either under its common seal or under the hand of an officer or attorney or other person duly authorised.

6. In case of joint shareholdings, any one of the joint shareholders may vote at the meeting, either in person or by proxy, in respect of the joint shareholding as if he/she were solely entitled thereto, but if more than one of such joint shareholders be present at the meeting, the vote of the senior joint shareholder who tenders a vote, whether in person or by proxy, will be accepted to the exclusion of the votes of the other joint shareholder(s) and for this purpose seniority will be determined by the order in which the names stand in the register of members of the Company in respect of the joint shareholding.

7. To be valid, this proxy form and the power of attorney or other authority (if any) under which it is signed or a notarially certified copy thereof must be deposited at the Company’s share registrar in Hong Kong, Union Registrars Limited at Suites 3301-04, 33rd Floor, Two Chinachem Exchange Square, 338 King’s Road, North Point, Hong Kong not less than 48 hours before the time fixed for holding the Meeting (or any adjournment thereof).

8. The proxy need not be a member of the Company but must attend the Meeting (or any adjournment thereof) in person to represent you.

9. Completion and return of this proxy form will not preclude you from attending and voting in person at the Meeting (or any adjournment thereof) if you wish to do so.

PERSONAL INFORMATION COLLECTION STATEMENT

Your supply of your and your proxy’s (or proxies’) name(s) and address(es) is on a voluntary basis for the purpose of processing your request for the appointment of a proxy (or proxies) and your voting instructions for the meeting of the Company (the “Purposes”). We may transfer your and your proxy’s (or proxies’) name(s) and address(es) to our agent, contractor, or third party service provider who provides administrative, computer and other services to us for use in connection with the Purposes and to such parties who are authorized by law to request the information or are otherwise relevant for the Purposes and need to receive the information. Your and your proxy’s (or proxies’) name(s) and address(es) will be retained for such period as may be necessary to fulfil the Purposes. Request for access to and/or correction of the relevant personal data can be made in accordance with the provisions of the Personal Data (Privacy) Ordinance and any such request should be in writing by mail to the Company/Union Registrars Limited at the above address.